Page last updated: 2024-10-29

indirubin-3'-monoxime and Insulin Resistance

indirubin-3'-monoxime has been researched along with Insulin Resistance in 2 studies

indirubin-3'-monoxime: has antiangiogenic activity
indirubin-3'-monoxime : A member of the class of biindoles that is indirubin in which the keto group at position 3' has undergone condensation with hydroxylamine to form the corresponding oxime.

Insulin Resistance: Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choudhary, SA1
Bora, N1
Banerjee, D1
Arora, L1
Das, AS1
Yadav, R1
Klotz, KN1
Pal, D1
Jha, AN1
Dasgupta, S1
Sharma, S1
Taliyan, R1

Other Studies

2 other studies available for indirubin-3'-monoxime and Insulin Resistance

ArticleYear
A novel small molecule A
    The Biochemical journal, 2019, 08-30, Volume: 476, Issue:16

    Topics: 3T3-L1 Cells; Adenosine A2 Receptor Agonists; Adipocytes; Animals; Indoles; Inflammation; Insulin Re

2019
Neuroprotective role of Indirubin-3'-monoxime, a GSKβ inhibitor in high fat diet induced cognitive impairment in mice.
    Biochemical and biophysical research communications, 2014, Oct-03, Volume: 452, Issue:4

    Topics: Animals; Brain; Brain-Derived Neurotrophic Factor; Cognition Disorders; Diet, High-Fat; Glycogen Syn

2014